Bench-to-bedside review: Oxygen as a drug

被引:0
|
作者
Haim Bitterman
机构
[1] The Ruth and Bruce Rappaport Faculty of Medicine,Department of Internal Medicine, Carmel Medical Center
[2] Technion – Israel Institute of Technology,undefined
来源
Critical Care | / 13卷
关键词
Carbon Monoxide Poisoning; Central Nervous System Toxicity; Hyperoxic Exposure; Hyperbaric Chamber; Normobaric Hyperoxia;
D O I
暂无
中图分类号
学科分类号
摘要
Oxygen is one of the most commonly used therapeutic agents. Injudicious use of oxygen at high partial pressures (hyperoxia) for unproven indications, its known toxic potential, and the acknowledged roles of reactive oxygen species in tissue injury led to skepticism regarding its use. A large body of data indicates that hyperoxia exerts an extensive profile of physiologic and pharmacologic effects that improve tissue oxygenation, exert anti-inflammatory and antibacterial effects, and augment tissue repair mechanisms. These data set the rationale for the use of hyperoxia in a list of clinical conditions characterized by tissue hypoxia, infection, and consequential impaired tissue repair. Data on regional hemodynamic effects of hyperoxia and recent compelling evidence on its anti-inflammatory actions incited a surge of interest in the potential therapeutic effects of hyperoxia in myocardial revascularization and protection, in traumatic and nontraumatic ischemicanoxic brain insults, and in prevention of surgical site infections and in alleviation of septic and nonseptic local and systemic inflammatory responses. Although the margin of safety between effective and potentially toxic doses of oxygen is relatively narrow, the ability to carefully control its dose, meticulous adherence to currently accepted therapeutic protocols, and individually tailored treatment regimens make it a cost-effective safe drug.
引用
收藏
相关论文
共 50 条
  • [1] Bench-to-bedside review: Oxygen as a drug
    Bitterman, Haim
    [J]. CRITICAL CARE, 2009, 13 (01): : 205
  • [2] Bench-to-bedside review: Lactate and the kidney
    Bellomo R.
    [J]. Critical Care, 6 (4): : 322 - 326
  • [3] Bench-to-bedside review: Cytopathic hypoxia
    Fink, MP
    [J]. CRITICAL CARE, 2002, 6 (06) : 491 - 499
  • [4] Bench-to-bedside review: Carbon dioxide
    Gerard Curley
    John G Laffey
    Brian P Kavanagh
    [J]. Critical Care, 14
  • [5] Bench-to-bedside review: Metabolism and nutrition
    Michaël P Casaer
    Dieter Mesotten
    Miet RC Schetz
    [J]. Critical Care, 12
  • [6] Abdominal compliance: A bench-to-bedside review
    Blaser, Annika Reintam
    Bjoerck, Martin
    De Keulenaer, Bart
    Regli, Adrian
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2015, 78 (05): : 1044 - 1053
  • [7] Bench-to-bedside review: Lactate and the lung
    Iscra F.
    Gullo A.
    Biolo G.
    [J]. Critical Care, 6 (4): : 327 - 329
  • [8] Bench-to-bedside review: Carbon dioxide
    Curley, Gerard
    Laffey, John G.
    Kavanagh, Brian P.
    [J]. CRITICAL CARE, 2010, 14 (02):
  • [9] Bench-to-bedside review: Cytopathic hypoxia
    Mitchell P Fink
    [J]. Critical Care, 6
  • [10] Bench-to-bedside review: Permissive hypercapnia
    O'Croinin, D
    Chonghaile, MN
    Higgins, B
    Laffey, JG
    [J]. CRITICAL CARE, 2005, 9 (01) : 51 - 59